Skip to main content

AQR CAPITAL MANAGEMENT LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1167557 Greenwich, CT

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$11,751,342
-$4,401,473 QoQ
Shares Held
527,913
-12.7% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 94.86335816697068.ToString("F0")% Shared 0.ToString("F0")% None 5.136641833029306.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. ACAD ranks #28 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,751,342 527,913
2025-12-31 $16,152,815 604,748
2025-09-30 $13,248,552 620,832
2025-06-30 $6,292,031 291,703
2025-03-31 $1,124,029 67,672
2024-12-31 $1,196,052 65,180
2024-09-30 $567,951 36,928
2024-06-30 $588,102 36,191
2024-03-31 $879,143 47,547
2023-12-31 $1,541,922 49,247
2023-09-30 $1,002,966 48,127
2023-06-30 $1,106,274 46,191
2023-03-31 $760,064 40,386
2022-12-31 $723,309 45,434
2022-09-30 $652,813 39,903
2022-06-30 $665,949 47,264
2022-03-31 $943,804 38,968
2021-12-31 $646,354 27,693
2021-03-31 $223,453 8,661
2020-12-31 $613,239 11,471
2020-09-30 $875,737 21,230
2020-06-30 $4,844,964 99,958
2020-03-31 $4,726,254 111,864